How skincare brands should evaluate a growth factor ingredient supplier.
Evaluate suppliers on identity, purity, stability, delivery data, formulation compatibility, clinical or ex vivo evidence, regulatory documentation, INCI strategy, manufacturing consistency, and technical support. A good supplier reduces development risk, not just sells a molecule. The most expensive ingredient on paper is often the cheapest in finished-product cost when its supplier is competent.
Buying a recombinant growth factor is not buying a commodity. The same INCI name from two different suppliers can mean two different products, two different stability profiles, and two different clinical outcomes. This is a practical checklist for brand R&D and procurement teams.
Evaluation criteria #
| Criterion | Why it matters | What to ask for |
|---|---|---|
| Identity | Confirms the molecule | Sequence confirmation, mass spec, ELISA cross-reference |
| Purity | Reduces unknown variables | SDS-PAGE, HPLC, endotoxin levels, host-cell protein limits |
| Stability | Predicts product shelf life | Accelerated and real-time stability with functional readout |
| Delivery system | Part of the active | Particle size, zeta potential, biomimetic surface data |
| Formulation compatibility | Real-world performance | Compatibility matrix across pH, preservatives, surfactants |
| Clinical evidence | Supports finished-product claims | Placebo-controlled trial data or ex vivo studies |
| Regulatory documentation | Market access | INCI naming, IFRA / global compliance, allergen documentation |
| Manufacturing consistency | Batch reliability | Multi-batch CoA data, quality system certifications |
| Technical support | Shortens development | Named technical contact, sample availability, scale-up support |
| Sustainability documentation | Brand storytelling | LCA data, production origin, supply chain transparency |
Red flags #
- Vague molecule identity or generic "growth factor blend" labeling
- No certificate of analysis per batch
- No stability protocol or only generic claims
- No functional or clinical evidence on a representative formula
- Reluctance to provide regulatory documentation in your target markets
- No clarity on whether the active ships with a delivery system
- Surprising INCI names that may not be accepted in your target markets
What to request before buying #
- Specification sheet with full identity and impurity profile
- Three recent certificates of analysis from different batches
- Accelerated stability data at 40 degrees Celsius and real-time at 25 degrees Celsius
- Formulation guidelines including pH, addition phase, recommended preservation
- Compatibility data against common surfactants and antioxidants
- Documented INCI strategy across major markets
- Clinical or ex vivo study report on a representative finished product
- Sustainability documentation and production origin
Commercial considerations #
- Compare cost per measurable outcome, not cost per kilo
- Validate against existing actives at realistic dose levels
- Negotiate exclusivity windows for differentiated delivery technology
- Confirm minimum order quantities and lead time for commercial launch
- Plan for at least one full stability cycle before locking the formula
Best for / Not ideal for #
- Defined molecule with multiple analytical confirmations
- Clinical evidence with placebo-controlled or comparator data
- Validated delivery system with characterization data
- Named technical contacts and fast response
- Regulatory dossier ready for your priority markets
- Generic class claims with no molecule-level data
- No batch-level CoA
- Stability "claims" with no protocol
- Reluctance to share clinical data under NDA
- Pricing that drops dramatically on volume without scientific rationale
What skincare brands should look for #
- Suppliers that behave like development partners
- Full technical and regulatory packages, not marketing-only datasheets
- Open communication about limitations, not over-promise
- Documented examples of finished products using the active
Frequently asked questions #
How should skincare brands evaluate a growth factor ingredient supplier?
On identity, purity, stability, delivery, evidence, regulatory documentation, manufacturing consistency, and technical support.
What documents should I request before buying a growth factor ingredient?
Spec sheet, batch CoAs, identity confirmation, microbiology, stability data, formulation guidelines, regulatory dossier, INCI documentation, and clinical or ex vivo evidence.
What are red flags in a growth factor supplier?
Vague identity, no batch CoA, no stability data, missing evidence, missing regulatory documentation, hidden delivery system, no pilot support.
Should the supplier provide delivery system data?
Yes, if the active ships with or relies on a delivery system.
How important is technical support from a supplier?
Very. Premium biotech actives are not commodities. Strong technical support shortens development cycles substantially.
Related: how to formulate with growth factors, best delivery system for growth factors, stability in cosmetic formulations.